Related Experiment Videos

[Cefotiam excretion into the bile after radical operation of congenital biliary atresia]

Insights

Prophylactic cefotiam (CTM) in infants undergoing biliary atresia surgery effectively reached high bile concentrations, exceeding pathogen minimum inhibitory levels. Successful surgery correlated with better CTM excretion, aiding biliary tract infection prevention.

Area of Science:

  • Pediatric Surgery
  • Pharmacokinetics
  • Infectious Disease

Context:

  • Congenital biliary atresia requires complex surgical repair, often involving cholangiojejunostomy.
  • Biliary tract infections are a significant post-operative complication.
  • Assessing antibiotic efficacy in bile is crucial for preventing surgical site infections.

Purpose:

  • To evaluate the biliary excretion and efficacy of prophylactic cefotiam (CTM) in infants after extrahepatic cholangiojejunostomy for biliary atresia.
  • To correlate CTM bile levels with surgical outcomes and liver function.
  • To determine if CTM concentrations in bile are sufficient to inhibit common biliary pathogens.

Summary:

  • Twelve infants received prophylactic cefotiam (50 mg/kg IV) post-cholangiojejunostomy for biliary atresia.
  • Higher cefotiam bile concentrations were observed in patients with successful anastomosis, good bile flow, and resolved jaundice.
  • Bile cefotiam levels consistently exceeded MIC80 values for key biliary pathogens, demonstrating clinical significance.

Impact:

  • Provides evidence for the clinical utility of cefotiam in preventing biliary tract infections in this vulnerable pediatric population.
  • Highlights the relationship between surgical success, liver function, and antibiotic pharmacokinetics in the bile.
  • Supports the use of cefotiam as an effective prophylactic agent in complex biliary surgeries.

Related Concept Videos